Data security breach affects health information management services

  • OpenLoop disclosed a data security incident involving personal information.
  • Investigation ongoing to assess the impact of the breach.
  • Affected users are being notified and provided with support.

OpenLoop, a healthcare data management company, has announced a data security incident that affects the privacy of personal information. The breach potentially impacts various individuals who use their health information management services. The company is actively working on investigating the incident to fully understand its scope and impact.

In response to the data security incident, OpenLoop is taking steps to notify affected users as well as provide them with resources to monitor their personal information. The company emphasizes its commitment to protecting the privacy and security of its users' data. As the investigation continues, updates will be provided to those affected by this incident.

OpenLoop is cooperating with relevant authorities and cybersecurity experts to address the situation. The company is reviewing its security protocols and aims to reinforce its efforts in data protection. Users are encouraged to remain vigilant and report any suspicious activity related to their personal information.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Pharmacelera Raises $6M to Expand in US and Enhance Drug Discovery Platform

Funding will support growth and technological advancements in drug discovery. Pharmacelera has…

BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation

Innovative automation enhances cancer research and immunological studies. AI-powered tools improve research…

NUNM Receives $1.5 Million Gift to Support Campus Expansion and Future Integrative Medicine Center

Major donation aims to enhance educational opportunities at NUNM. NUNM receives a…

WuXi Biologics and Vertex Enter Research Agreement for T-Cell Engager

Collaboration focuses on advancing T-cell engager therapies for cancer treatment WuXi Biologics…